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Abstract
HIV vaccine trials with minors will likely require parental permission and informed assent from 
adolescents. For this to be a valid process, the information needs to be presented in a manner that 
promotes adolescent comprehension. Previous studies suggest that adolescent comprehension of 
assent is often insufficient. We developed an interactive web-based assent that included 
interspersed quiz questions for a hypothetical HIV vaccine trial. Efficacy of the web-based assent 
was compared to a standard paper assent with and without interspersed questions. One hundred 
twenty teen participants, ages 15-17 years, from 5 community organizations were randomized to 
self-administered web-based assent (n=60) or investigator-administered paper assent with (n=29) 
or without (n=31) interspersed quiz questions. After reviewing the assent, participants completed a 
27 item comprehension test. Comprehension scores were compared between groups. The mean 
number of correctly answered questions were 21.2 for the full paper group and 21.1 for the web-
based group (t(118)=-0.08, p=0.94). Scores were 20.2 for the paper without interspersed questions 
sub-group and 22.1 for the paper with interspersed questions sub-group (t(58)=1.96, p=0.055). 
Participants in the web-based group performed as well on the comprehension test as those in the 
paper group, and those in the paper with questions sub-group performed better than those in the 
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paper without questions sub-group, suggesting that interspersed quiz questions may improve 
understanding of a traditional paper assent. The minimal investigator time and standardized 
administration of the web-based assent as well as ability to tailor the assent discussion to topics 
identified by incorrect comprehension test responses are advantages worthy of further 
investigation.
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Informed consent; clinical trials; children; HIV infection; AIDS; Research ethics; informed 
consent; adolescence; computer-assisted instruction
Introduction
Efforts to develop an effective Human Immunodeficiency Virus (HIV) vaccine remain a 
high priority in the battle to control the HIV epidemic. Once a candidate vaccine is shown to 
be safe and effective in adults, trials in adolescents are likely to commence. In future trials 
involving adolescents, those who have reached the age of majority will provide informed 
consent as adults. However, younger adolescents will be asked to provide informed assent; 
additionally, parents of minors will be asked to provide parental permission. It is possible 
that individual IRBs may grant investigators a waiver for the requirement of parental 
permission for minor adolescent participation in HIV vaccine trials, but given that such a 
trial would carry more than minimal risk, this cannot be assumed.
The appropriate form and content of assent for adolescent research participants is not well 
specified. Unlike informed consent, federal regulations do not specify any required elements 
for informed assent (Nelson R & Amdur RJ, 2007). However, developmental psychologists 
have noted that as a child moves through adolescence, s/he develops an ability to understand 
increasingly complex and abstract concepts. Research has generally shown that by age 14 or 
15 years, most adolescents are able to function as well as adult research participants in most 
circumstances (C.E. Lewis, M.A. Lewis, & Ifekwunigue, 1978; Petersen & Leffert, 1995, 
Susman, Dorn, & Fletcher, 1992; Weithorn & Campbell, 1982). We believe that the 
cognitive maturity of 15 to 17 year olds is sufficient to provide assent that contains all 
information elements of informed consent. Furthermore, older adolescents should be 
provided with enough information about a trial so that they can understand and appreciate 
the risks and benefits of participation and make a well-reasoned and well informed decision 
about whether or not to participate. To be a valid process, information needs to be presented 
in a manner that promotes adolescent comprehension.
The best way to approach informed assent for adolescent HIV vaccine research is unclear 
since a large proportion of adult research participants do not understand the information 
presented during the informed consent process (Flory J & Emanuel E, 2004; Siminoff, 
2003). Issues of concern include low health literacy, not understanding the chance nature of 
treatment assignments in a placebo controlled trial (Howard & DeMets, 1981), and 
therapeutic misconception in which the research participant “fails to grasp the distinction 
between the imperatives of clinical trials and of ordinary treatment, and inaccurately 
attributes therapeutic intent to research procedures” (Appelbaum, Roth, & Lidz, 1982; 
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Appelbaum, Roth, Lidz, Benson, & Winslade, 1987; Joffe, Cook, Cleary, Clark, & Weeks, 
2001; Lidz CW & Appelbaum PS, 2002). Simon et al have described a related concept that 
is more relevant to a vaccine trial, preventive misconception, “the overestimate in 
probability or level of personal protection that is afforded by being enrolled in a trial of a 
preventive intervention” (Hosek SG & Zimet GD, 2012; Ott et al., 2013; Simon AE, Wu 
AW, Lavori PW, & Sugarman J, 2007).
An important contribution to our understanding of assent content for adolescent HIV 
research participants comes from the Adolescent Medicine Trials Network for HIV/AIDS 
Interventions (Murphy DA et al., 2007). An HIV vaccine trial information pamphlet was 
simplified by reducing reading level from 8th to 5th grade, reorganizing the form to improve 
flow, removing redundant information, and adding illustrations. (Murphy DA et al., 2007). 
Adolescents randomized to the simplified assent form scored significantly better on a post-
presentation comprehension quiz than those randomized to the standard form (Murphy DA 
et al., 2007).
Few studies have evaluated the use of multimedia in the assent process. One study 
demonstrated significant improvement in understanding with use of a multi-media assent 
process to explain non-invasive radiology procedures to 11 to 14 year olds and parents 
(O'Lonergan TA & Forster-Harwood JE, 2011). However, in contrast to an HIV vaccine 
trial, the information presented was very brief, straightforward, and presented no more than 
minimal risk (O'Lonergan TA & Forster-Harwood JE, 2011).
Computers have been used in educational settings for more than three decades. A review of 
35 research reports found that computer assisted instruction (CAI) supplemented by 
traditional teacher directed instruction resulted in superior student achievement as compared 
to traditional instruction alone and led to more positive student attitudes and increased 
motivation to learn (Cotton, 1991). CAI was found to be especially effective with lower 
achieving and economically disadvantaged students (Cotton, 1991). More recently, web-
based approaches have successfully been used to assist adolescents who have chronic 
disease with preparation for transition to adult care, adolescents who have ADHD with 
acquisition of content knowledge, and a range of adolescents with education on adolescent 
health (Borzekowski, McCarthy, & Rosenfeld, 2012; Fabio & Antonietti, 2012; Huang, et 
al., 2014). Twenty first century adolescents are digital natives, having grown up with the 
internet, and prefer working online to on paper. The Pew Internet & American Life Project 
found that 93% of 12 to 17 year olds and 89% of 18 to 24 year olds use the Internet (Pew 
Internet & American Life Project 2009).
We hypothesized that a web-based assent would appeal to adolescents and result in 
increased motivation, improved retention, and better comprehension. To test this hypothesis, 
we compared a web-based assent to a previously developed paper assent.
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Intervention Development
Web-Based Assent
Development of the web-based assent was informed by several phases of formative work. 
We conducted eight focus groups to learn what adolescents would want to know before 
participating in research and what research concepts are most challenging to understand. 
Findings have been described previously (Blake DR, Lemay CA, Kearney MH, & Mazor 
KM, 2011).
Fourteen cognitive interviews were conducted with adolescents as they read through the 
simplified assent form developed by Murphy et al (Murphy DA et al., 2007). This process 
identified information that continued to be difficult for teens to comprehend. Using findings 
from the focus groups and cognitive interviews, three topic areas were identified for video 
animation: 1) What is a vaccine and how does it work? 2) What is a placebo? and 3) The 
HIV test vaccine: will it work?
The content of Murphy's previously simplified assent(Murphy DA et al., 2007) was 
converted into a web-based program. An introduction was added, priming participants to 
consider the 8 elements of informed consent as they pertained to the hypothetical study. 
Content was split into smaller segments to conform to adolescent expectations for font size 
and ‘white space’ of a presentation viewed on a computer screen. Font type (comic sans) 
and background and font color (white lettering on black background) were chosen after 
consultation with youth. Color was used liberally to emphasize points. Clip art was included 
to help illustrate concepts and to increase visual appeal. Words identified as difficult to 
understand during cognitive interviews were underlined to denote hypertext; the definition 
popped up on the screen when a participant rolled the mouse over the word. All content was 
narrated to assist those with low literacy.
Fourteen multiple choice questions were developed to assess understanding of each element 
of informed consent. Questions were interspersed throughout the web-based assent, and 
participants were periodically required to answer a question before proceeding to the next 
section. The program provided feedback on whether the selected response was correct and 
why incorrect responses were wrong.
Paper Assents
We made minor modifications to Murphy's simplified paper assent (Murphy DA et al., 
2007) including the addition of an introduction page, which mirrored the introduction 
described above for the web-based program. Some pages were reformatted to keep linked 
sections together in a three page spread for ease of reading. Two versions of the paper assent 
were created: one included the 14 interspersed quiz questions with an answer key to mimic 
the web-based assent, and the other did not.
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Methods
Participants
A sample size of 60 subjects per group (web-based and paper) was chosen to provide 80% 
power to detect a predicted effect size of 0.30 between the proportion of participants 
answering at least 80% questions correctly in the web-based group versus the paper group. 
As procedures were refined, the decision was made to subdivide the initial paper group 
sample of 60 into paper assent with interspersed questions and paper assent without 
interspersed questions to isolate the effect of the interspersed questions on comprehension.
One hundred twenty adolescents were recruited from five youth-serving agencies. Eligibility 
criteria were age 15 to 17 years and ability to read and understand English.
Written informed assent was obtained from participants, and a waiver of the parental 
permission requirement was granted. Research procedures were approved by our Medical 
School's Committee for the Protection of Human Subjects in Research.
Measures
Participant race, ethnicity, gender, age, health insurance status, first language spoken, and 
HIV testing history were collected. A multiple choice question evaluated participant 
willingness to join the HIV vaccine trial if it were offered that day.
A comprehension test consisting of 27 questions was developed to measure participant 
understanding of assent content. Response options were true, false, and unsure. The unsure 
option was included to discourage guessing, and was scored as incorrect.
Procedures
A random number table was used to generate intervention assignments to one of three 
groups: 1) Web-based assent (n = 60), 2) Paper assent with interspersed quiz questions (n = 
29), or 3) Paper assent without interspersed questions (n = 31). Assignments were placed in 
sealed envelopes by the principal investigator and opened sequentially by a co-investigator 
as participants were recruited.
All participants completed assessment measures on a computer regardless of assigned group. 
After completing the assessment, participants were administered the Sentence 
Comprehension subtest of the Wide Range Achievement Test: Fourth Edition (WRAT-4) to 
assess literacy. The WRAT-4 is a “norm-referenced test that measures basic academic 
skills” (PAR, Inc., Lutz, FL). The Sentence Comprehension grade equivalent score was 
computed for each participant. One investigator (CAL) administered the assent and 
assessment procedures to all participants.
Administration of Web-based Assent—The investigator answered questions, but 
participants navigated the program independently. Use of headphones to listen to narration 
was optional. Once the participant completed the web-based assent, the investigator 
answered questions about the hypothetical study and participants completed the web-based 
assessment and the WRAT-4.
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Administration of Paper Assent without Questions—The investigator read the 
assent to the participant, pausing at the end of each page for questions. After reviewing the 
entire assent, participants completed the web-based assessment and the WRAT-4.
Administration of Paper Assent with Questions—This process was identical to the 
Paper assent without Questions except that questions were interspersed throughout the 
assent to check understanding. After each question was answered, participants were 
provided with an answer key. Incorrect answers were discussed, the correct answer provided 
and if needed, information previously viewed from the paper assent was reread.
Analyses
Statistical analyses were conducted with IBM SPSS (Statistical Package for the Social 
Sciences) Statistics Version 20.0 (Chicago, IL). Our primary outcome, comprehension of the 
assent, was measured in two distinct ways: 1) mean number of correctly answered true/false 
comprehension test questions and 2) proportion of participants who answered at least 80% 
of the true/false comprehension test questions correctly. We chose a threshold of 80% to be 
consistent with other investigators who have used 80% as a minimum standard for adequate 
comprehension of HIV vaccine information (Koblin BA, 1998; Murphy DA et al., 2007).
The primary outcome was first tested for all paper (n=60) versus computer (n=60) and then 
tested for paper with interspersed questions (n=29) versus paper without interspersed 
questions (n=31). Each of these outcomes was tested separately using t tests for independent 
continuous outcomes and Chi-square tests for proportions. The relationship between literacy 
and comprehension scores, for each type of assent, was measured using linear regression, 
and a generalized linear model was used to quantify possible differences between the sizes 
of these relationships.
Results
Baseline evaluation of participant characteristics is summarized in Table 1. Amongst the full 
sample, the average comprehension score was 21.1 out of a possible 27 (78.1%). Table 2 
provides results of the comprehension test for each assignment group.
The mean scores were similar in the computer group and the paper group. The mean score 
was highest in the paper with interspersed questions group and lowest for the paper without 
questions group. Although the difference between the two groups in the latter comparison 
was not statistically significant, the 95% confidence intervals overlapped by an increment of 
less than one question.
There was a positive relationship between comprehension score and literacy level for the full 
sample (adjusted R2 = 0.36; Beta=0.60, p<0.001). This relationship varied between assent 
assignment groups (Figure), but the differences were not statistically significant (p = 0.93).
If enrollment in the hypothetical HIV vaccine study were offered on the day that participants 
reviewed the assent, those in the two paper assent groups were more likely to say that they 
were willing (definitely or probably) to join the study than those in the web-based group 
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(X2(1) =4.04, p=0.04), and although not statistically significant a larger proportion in the 
paper without questions group (0.65) were willing than in the paper with questions group 
(0.48).
Results for each of the individual true/false comprehension questions are found in Table 3. 
There is substantial variability in the proportion answering individual items correctly within 
assignment groups and between groups.
Headphones were used by 72% (43 of 60) of the participants randomized to the web-based 
program. Those who did not use headphones answered an average of one more question 
correctly than those who did use headphones (21.8 versus 20.8). Furthermore, the average 
literacy grade equivalent of those who did not use headphones was 8.0 (95% CI [6.7, 9.2]) 
versus 6.8 (95% CI [6.1, 7.5]) in the group who did use headphones, but the difference in 
this small sample was not statistically significant (p = 0.1).
Discussion
We evaluated a web-based assent for 15 to 17 year old adolescents who were asked to 
consider participation in a hypothetical HIV vaccine trial. We chose this age range because 
this group is likely to be cognitively mature enough to provide informed assent equivalent to 
the consent provided by their slightly older peers who have reached the age of majority. Our 
web-based assent included many features intended to appeal to youth including, liberal use 
of color, interesting font, clip art, hypertext, video animations, and optional audio. We used 
a variation on the ‘testing with feedback’ method, an approach that resulted in improved 
comprehension in a previous study on consent for an HIV vaccine trial (Coletti et al., 2003). 
Our participants answered questions about information presented in each section and 
received feedback on incorrectly answered questions before progressing to the next section.
We hypothesized that asking questions after each section would improve adolescent 
understanding by reinforcing information presented. Although no clear relationship emerged 
to suggest that interspersed questions led to answering more comprehension questions 
correctly, the correct response rate was higher than 80% for more comprehension questions 
in the web-based and paper with questions groups than in the paper without questions group.
We hypothesized that our intervention would be more successful than previous computer 
interventions with adults because today's adolescents are digital natives who often prefer 
web-based technologies (DeBell & Chapman, 2003). Furthermore, we implemented a text-
to-speech feature into the web-based application, thus diminishing the level of reading 
ability required. In fact, the average literacy grade equivalent among those choosing to wear 
headphones was 1.2 grades lower than those choosing not to wear headphones, suggesting 
that participants with lower literacy may have found the audio feature to be helpful.
Simulation trials are often criticized for possible bias toward the experimental condition 
because these designs usually evaluate only information obtained from the consent form and 
do not consider the entire consent process, which typically includes a discussion about the 
information in the consent form (Flory J & Emanuel E, 2004). However, our design may 
actually have biased results against the experimental condition because participants 
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randomized to the web-based assent were not asked if they had questions until they 
completed the web-based program. In contrast, participants assigned to a paper assent were 
asked if they had questions after completing each page of the assent.
We can only speculate about the comparability of assent administered by our study 
investigator versus that of typical study staff because we did not compare our investigator's 
technique to that of other personnel recruiting participants for a real clinical trial. However, 
in our study the paper assents across both conditions were administered by a highly trained 
researcher with a background in nursing, whose only task was to explain this hypothetical 
study to participants and answer their questions. In contrast to a typical clinical trial, our 
investigator was not involved in other aspects of a clinical practice and had no other 
responsibilities or demands on her time. In this way, the rigorous assent procedures used 
here represented an ideal condition. It stands to reason that variability will exist in the 
quality of the assent process depending on who is conducting it, a topic worthy of additional 
research as well as rationale for developing methods to standardize the process.
Although we found no statistically significant difference in comprehension between the 
web-based assent and the two versions of the paper assent, several important lessons were 
learned. First, it is noteworthy that in this sample the web-based assent performed as well as 
the traditional paper method. This finding might lead investigators to develop a menu of 
options to offer trial participants. If recruiting a large sample, developing a web-based assent 
to introduce the study will standardize the process and potentially save investigator time. 
Participants can self-select whether to use audio and can move at their own pace. 
Comprehension test results could be used to determine which concepts a participant 
misunderstood. Study personnel time could then be used more effectively to tailor the assent 
discussion to clear up confusion and answer participant questions. If engaging in a smaller 
study with a smaller budget, developing a web-based assent may not be feasible, but 
incorporating interspersed questions within a paper assent may improve participant 
comprehension and understanding of the study.
If this approach were adopted, some concepts will likely require more attention than others. 
Our findings raise concern about several misunderstandings. Specifically, more than one 
quarter of participants in all three assignment groups appeared not to understand that a study 
vaccine could harm a participant (Question 3), that needing special HIV tests could cause 
personal problems (Question 15), and that the anticipated outcome of the candidate vaccine 
was preventive rather than curative (Question 22).
It is possible that individual IRBs will determine that older minor adolescents may provide 
their own consent without parental permission for participation in an HIV vaccine trial, 
especially if adolescents in their locations are allowed under state law to consent for 
vaccines for clinical care (Nelson, LL Lewis, Struble, & Wood, 2010). In fact, the Society 
for Adolescent Medicine (SAM), in its position paper on Guidelines for Adolescent Health 
Research, also recognized that adolescents at this age are generally capable of providing 
their own consent for research that involves no more than minimal risk (Santelli et al, 2003). 
However, the Guidelines recommend that for research involving greater than minimal risk 
investigators should make an individual assessment of each minor participant's capacity to 
Blake et al. Page 8
AIDS Care. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
provide consent (Santelli et al, 2003). A consent process that improves adolescent 
understanding and appreciation of risks and benefits of the research would likely be a 
prerequisite to consideration of waiving the requirement for parental permission for an HIV 
vaccine trial.
Our study had limitations. First, a simulated study design was necessary because a candidate 
HIV vaccine that is ready for trials with adolescents does not yet exist. However, when such 
a vaccine is ready for testing in adolescents, institutional review boards are more likely to 
approve adolescent trials if an assent with demonstrated acceptable comprehension by 
minors is already available. Second, some of our results were limited by our sample size, 
which was based on a predicted effect size that was not achieved. The sample was not large 
enough to determine whether some of the clinically significant secondary findings were 
statistically significant (e.g. difference in comprehension scores and willingness to join the 
study between the paper with questions group versus the paper without questions group, and 
difference in literacy between those in the web-based group who chose to use headphones 
and those who chose not to). Future validation studies are needed where the process can be 
replicated in a real HIV vaccine trial environment and we can explore whether use of a web-
based assent plus review of incorrect evaluation answers improves overall understanding by 
adolescents.
Conclusion
Our web-based method of assent appears to perform as well as a traditional paper assent. 
Use of this approach has the potential to standardize the initial assent process, saving 
personnel time in large clinical trials, and utilizing study personnel more effectively to 
review results of a comprehension test and tailor the assent discussion to the concepts that 
were not well understood. Participants can be given the choice to use the text-to-speech 
feature depending on their literacy and comfort. Alternatively, youth could be given the 
choice of assent information methods best suited to them. If using a traditional paper assent, 
the addition of interspersed questions throughout the assent may improve overall 
comprehension.
Acknowledgments
The authors thank Debra A Murphy, PhD, for her consultation and for allowing us to use her simplified consent in 
this study. We thank Charles W. Lidz, PhD for his consultation and expertise on consent and ethics. We are grateful 
to all of the youth who participated in this study.
All phases of this study were supported by NIH grant, 1R21HD057786-01 from the National Institute of Child 
Health and Human Development (NICHD). Its contents are solely the responsibility of the authors and do not 
necessarily represent the official views of NICHD.
References
Appelbaum, Paul S.; Roth, LH.; Lidz, CW. The therapeutic misconception: informed consent in 
psychiatric research. International Journal of Law and Psychiatry. 1982; 5:319–329. [PubMed: 
6135666] 
Appelbaum, Paul S.; Roth, LH.; Lidz, CW.; Benson, P.; Winslade, W. False hopes and best data: 
consent to research and the therapeutic misconception. Hastings Center Report. 1987; 17(2):20–24. 
[PubMed: 3294743] 
Blake et al. Page 9
AIDS Care. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Blake DR, Lemay CA, Kearney MH, Mazor KM. Adolescents' understanding of research concepts: a 
focus group study. Arch Pediatr Adolesc Med. 2011; 165:533–539. [PubMed: 21646586] 
Borzekowski DLG, McCarthy C, Rosenfeld WD. Ten years of TeenHealthFX.com: A case study of an 
adolescent health web site. Pediatr Clin n Am. 2012; 59:717–727.
Coletti, Anne S.; Heagerty, Patrick; Sheon, Amy; Gross, Michael; Koblin, Beryl A.; Metzger, David; 
Seage, George R, III. Randomized, controlled evaluation of a prototype informed consent process 
for HIV vaccine efficacy trials. Journal of Acquired Immune Deficiency Syndrome. 2003; 32:161–
169.
Cotton, Kathleen. Close Up #10: Computer-Assisted InstructionSchool Improvement Research Series: 
Northwest Regional Educational Laboratory. 1991. Retrieved from http://educationnorthwest.org/
resource/825
DeBell, Matthew; Chapman, Chris. Computer and Internet Use by Children and Adolescents in 2001. 
Washington, DC: U.S. Department of Education, National Center for Education Statistics; 2003. 
Fabio RA, Antonietti A. Effects of hypermedia instruction on declarative, conditional and procedural 
knowledge in ADHD students. Research in Developmental Disabilities. 2012; 33:2028–2039. 
[PubMed: 22750359] 
Flory J, Emanuel E. Interventions to improve research participants' understanding in informed consent 
for research: a systematic review. JAMA. 2004; 292(13):1593–1601. [PubMed: 15467062] 
Hosek SG, Zimet GD. Behavioral Considerations for Engaging Youth in HIV Clinical Research. J 
Acquir Immune Defic Syndr. 2012; 54:S25–S30. [PubMed: 20571420] 
Howard JM, DeMets D. How informed is informed consent: the BHAT experience. Controlled 
Clinical Trials. 1981; 2(4):287–303. [PubMed: 6120794] 
Huang JS, Terrones L, Tompane T, Dillon L, Pian M, Gottschalk M, Norman GJ, Bartholomew LK. 
Preparing adolescents with chronic disease for transition to adult care: a technology program. 
Pediatrics. 2014; 133(6):e1639–e1646. [PubMed: 24843066] 
Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC. Quality of informed consent in cancer clinical 
trials: a cross-sectional survey. Lancet. 2001; 358:1772–1777. [PubMed: 11734235] 
Koblin BA, Heagerty P, Sheon A, et al. Readiness of high-risk populations in the HIV Network for 
Prevention Trials to participate in HIV vaccine efficacy trials in the United States. AIDS. 1998; 
12:785–793. [PubMed: 9619811] 
Lewis CE, Lewis MA, Ifekwunigue M. Informed consent by children and participation in an influenza 
vaccine trial. American Journal of Public Health. 1978; 68:1079–1082. [PubMed: 717615] 
Lidz CW, Appelbaum PS. The therapeutic misconception: problems and solutions. Med Care. 2002; 
40:V55–V63. [PubMed: 12226586] 
Murphy DA, Hoffman D, Seage GR, Belzer M, Xu J, Durako SJ, Geiger M. the Adolescent Trials 
Network for HIV/AIDS Interventions. Improving comprehension for HIV vaccine trial 
information among adolescents at risk for HIV. AIDS Care. 2007; 19(1):42–51. [PubMed: 
17265577] 
Nelson, R.; Amdur, RJ. Research Involving Children. In: Amdur, RJ.; Bankert, EA., editors. 
Institutional Review Board: Member Handbook. Second. Boston, MA: Jones and Bartlett 
Publishers; 2007. p. 187-193.
Nelson RM, Lewis LL, Struble K, Wood SF. Ethical and regulatory considerations for the inclusion of 
adolescents in HIV biomedical prevention research. J Acquir Immune Defic Syndr. 2010; 54:S18–
S24. [PubMed: 20571419] 
O'Lonergan TA, Forster-Harwood JE. Novel approach to parental permission and child assent for 
research: improving comprehension. Pediatrics. 2011; 127:917–924. [PubMed: 21518711] 
Ott, Mary A.; Alexander, Andreia B.; Lally, M.; Steever, John B.; Zimet, Gregory D. the Adolescent 
Medicine Trials Network (ATN) for HIV/AIDS Interventions. Preventive misconception and 
adolescents' knowledge about HIV vaccine trials. J Med Ethics. 2013; 39:765–771. [PubMed: 
23355050] 
Petersen AC, Leffert N. Developmental issues influencing guidelines for adolescent health research: a 
review. Journal of Adolescent Health. 1995; 17(5):298–305. [PubMed: 8924434] 
Pew Internet & American Life Project. Generations online in 2009. 2009. Retrieved from http://
www.pewinternet.org/2009/01/28/generations-online-in-2009/
Blake et al. Page 10
AIDS Care. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Santelli JS, Rogers AS, Rosenfeld WD, et al. Guidelines for Adolescent Health Research: A position 
paper of the Society for Adolescent Medicine. Journal of Adolescent Health. 2003; 33(5):396–409. 
[PubMed: 14596961] 
Siminoff, Laura A. Toward improving the informed consent process in research with humans. IRB: 
Ethics & Human Research. 2003; 25 Supplement(5):S1–S3. [PubMed: 14870728] 
Simon AE, Wu AW, Lavori PW, Sugarman J. Preventive misconception: Its nature, presence, and 
ethical implications for research. Am J Prev Med. 2007; 32(5):370–374. [PubMed: 17478261] 
Susman EJ, Dorn LD, Fletcher JC. Participation in biomedical research: the consent process as viewed 
by children, adolescents, young adults, and physicians. Journal of Pediatrics. 1992; 121(4):547–
552. [PubMed: 1403387] 
Weithorn LA, Campbell SB. The competency of children and adolescents to make informed treatment 
decisions. Child Development. 1982; 53:1589–1598. [PubMed: 7172783] 
Blake et al. Page 11
AIDS Care. Author manuscript; available in PMC 2016 August 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure. 
Relationship of assent comprehension score and literacy grade equivalent measured by 
linear regression (adjusted R2) for each assignment group.
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Table 1
Participant Characteristics
Participant Characteristic Computer N=60 Paper with Interspersed 
Questions N=29
Paper without 
Interspersed Questions 
N=31
Statistical Test
Age mean yrs [95% CI] 16.0 [15.7, 16.2] 16.3 [16.0, 16.6] 15.9 [15.6, 16.2] F(2,117)=1.94, p=0.15
Female 47% 52% 45% X2 (2)=0.29, p=0.86
Hispanic 43% 45% 55% X2 (2)=1.14, p=0.57
RACE X2 (8)=7.63, p=0.47
Asian 12% 24% 16%
Black 28% 28% 23%
White 17% 7% 6%
Multiracial 18% 10% 29%
Other1 25% 31% 26%
FIRST LANGUAGE X2 (6)=4.23, p=0.65
English 73% 65% 77%
Spanish 20% 21% 16%
Vietnamese 2% 7% 7%
Other 5% 7% 0
INSURANCE X2 (6)=3.97, p=0.68
Private 12% 17% 23%
Public 70% 59% 55%
None 2% 0 3%
Unsure 17% 24% 19%
Previous HIV test 28% 34% 23% X2 (2)=1.04, p=0.59
LITERACY
Mean grade equivalent2[95% CI] 7.1 [6.5, 7.8] 7.4 [6.2, 8.6] 7.7 [6.5, 8.8] F(2,117)=0.38, p=0.69
1
Most who chose Other, wrote in some subcategory of Hispanic (e.g. Puerto Rican, Dominican)
2Sentence comprehension
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Table 3
Correct Responses for True/False Evaluation Questions
True/False Evaluation Question Overall N=120 Group 1 
Computer 
N=60
Group 2 
Paper with 
N=29
Group 3 
Paper w/out 
N=31
1) All of the people who join the study will get a shot that we know will 
protect them from HIV.
105 (88%) 52 (87%) 27 (93%) 26 (84%)
2) If I join the study, I will be asked to give blood for tests. 109 (91%) 53 (88%) 28 (97%) 28 (90%)
3) Researchers could never test vaccines on people that might cause 
health problems.
50 (42%) 22 (37%) 15 (52%) 13 (42%)
4) Some of the people who join the study will get a placebo instead of 
the test vaccine.
108 (90%) 55 (92%) 25 (86%) 28 (90%)
5) If I join the study, I'll have to take special HIV tests instead of regular 
HIV tests.
94 (78%) 49 (82%) 20 (69%) 25 (81%)
6) One goal of this study is to find out whether the vaccine we are testing 
will protect people from catching HIV.
98 (82%) 50 (83%) 22 (76%) 26 (84%)
7) The study shots and blood tests may hurt a little and make me feel bad 
for a few days.
110 (92%) 53 (88%) 28 (97%) 29 (94%)
8) If I join the study, I will be asked to take research pills for 2 years. 81 (68%) 43 (72%) 17 (59%) 21 (68%)
9) The test vaccine could make it look like I have HIV even if I don't. 93 (78%) 40 (67%) 27 (93%) 26 (84%)
10) The placebo should work almost as well. 90 (75%) 48 (80%) 23 (79%) 19 (61%)
11) This study will help to find out if the test vaccine causes health 
problems.
84 (70%) 37 (62%) 24 (83%) 23 (74%)
12) The study staff will guarantee that no one outside of the study finds 
out any private information about me.
48 (40%) 30 (50%) 15 (52%) 3 (10%)
13) If I join the study, the shots I get could cause harmful side effects. 100 (83%) 55 (92%) 25 (86%) 20 (64%)
14) If I join the study, the person who gives me the shots will decide 
whether I get test vaccine or placebo.
96 (80%) 54 (90%) 25 (86%) 17 (55%)
15) Not being able to take regular HIV tests could cause me personal 
problems.
85 (71%) 42 (70%) 21 (72%) 22 (71%)
16) If I join the study, I will be asked to come to the study clinic for at 
least 10 visits.
68 (57%) 25 (42%) 20 (69%) 23 (74%)
17) While I am in the study, I won't be told whether my shots contain test 
vaccine or placebo.
102 (85%) 47 (78%) 25 (86%) 30 (97%)
18) My participation in this study could help other people. 113 (94%) 55 (92%) 27 (93%) 31 (100%)
19) If I join the study I can't drop out because I made an agreement with 
the researchers.
110 (92%) 54 (90%) 28 (97%) 28 (90%)
20) The study doctors and nurses will take care of all of my medical 
problems even if they are not caused by the study shots.
87 (73%) 50 (83%) 19 (66%) 18 (58%)
21) If the researchers find that I have HIV, they will tell the state health 
department.
101 (84%) 50 (83%) 27 (93%) 24 (77%)
22) The vaccine that is being tested in this study could cure an HIV 
infection.
74 (62%) 40 (67%) 20 (69%) 14 (45%)
23) I don't have to join this study if I don't want to. 119 (99%) 59 (98%) 29 (100%) 31 (100%)
24) If I join the study, I can count on the shots I get to protect me from 
catching HIV.
103 (86%) 51 (85%) 26 (90%) 26 (84%)
25) Getting shots in a research study is just as good for my health as 
getting shots at my doctor's office.
81 (68%) 39 (65%) 22 (76%) 20 (64%)
26) It is okay for a female to become pregnant during the study. 119 (99%) 59 (98%) 29 (100%) 31 (100%)
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True/False Evaluation Question Overall N=120 Group 1 
Computer 
N=60
Group 2 
Paper with 
N=29
Group 3 
Paper w/out 
N=31
27) I will receive free health care for any medical problems that are 
directly related to the study.
107 (89%) 54 (90%) 28 (97%) 25 (81%)
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